Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines

被引：8
|
作者：
Dizdar, Omer [1 ]
Dede, Didem S. [1 ]
Bulut, Nilufer [1 ]
Altundag, Kadri [1 ]
机构：
[1] Hacettepe Univ, Inst Oncol, Dept Med Oncol, TR-06100 Ankara, Turkey
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2008年 / 107卷 / 02期
关键词：
Public Health; Breast Cancer; Cancer Cell; Estrogen; Estrogen Receptor;
D O I：
10.1007/s10549-007-9551-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：303 / 303
页数：1
相关论文
共 50 条
  • [1] Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines
    Omer Dizdar
    Didem S. Dede
    Nilufer Bulut
    Kadri Altundag
    Breast Cancer Research and Treatment, 2008, 107 : 303 - 303
  • [2] C-kit and PDGFRA gene mutations in triple negative breast cancer
    Zhu, Yun
    Wang, Yan
    Guan, Bing
    Rao, Qiu
    Wang, Jiandong
    Ma, Henghui
    Zhang, Zhihong
    Zhou, Xiaojun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (07): : 4280 - 4285
  • [3] Synergy of Ixabepilone and Dasatinib in Triple Negative Breast Cancer Cell Lines
    Ismail-Khan, R. R.
    Marichion, D. C.
    Cubitt, C. L.
    Lancaster, J. M.
    CANCER RESEARCH, 2010, 70
  • [4] Bosutinib Reduces the Efficacy of Dasatinib in Triple-negative Breast Cancer Cell Lines
    Tarpley, Mike
    Abdissa, Temesgen T.
    Johnson, Gary L.
    Scott, John E.
    ANTICANCER RESEARCH, 2014, 34 (04) : 1629 - 1635
  • [5] Immunohistochemical Expression of Epidermal Growth Factor Receptor and c-Kit in Triple Negative Breast Cancer
    Ahmed, Rabia
    Din, Hafeez Ud
    Akhtar, Farhan
    Afzal, Saeed
    Muhammad, Iqbal
    Hashmi, Shoaib Naiyar
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2016, 26 (07): : 570 - 572
  • [6] Dasatinib shows different cytotoxicity in triple-negative breast cancer cell lines.
    Haga, Yuya
    Higashisaka, Kazuma
    Yang, Lili
    Sekine, Naoki
    Nagano, Kazuya
    Tsutsumi, Yasuo
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 27 - 28
  • [7] Expression of androgen receptors and c-kit (CD117) in triple-negative breast cancer
    Rogov, Y.
    Krylov, A.
    VIRCHOWS ARCHIV, 2017, 471 : S64 - S65
  • [8] Effect of afatinib alone and in combination with dasatinib in triple-negative breast cancer cell lines.
    Ibrahim, Mohamed F. K.
    Canonici, Alexandra
    Collins, Denis
    Crown, John
    O'Donovan, Norma
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Overcoming EGFR Resistance Using Dasatinib in Combination with Cetuximab and Cisplatin in Triple Negative Breast Cancer Cell Lines.
    Kim, E. M. H.
    Gartner, E.
    Choi, L.
    Boerner, J.
    CANCER RESEARCH, 2011, 71
  • [10] c-Kit Induces Migration of Triple-Negative Breast Cancer Cells and Is a Promising Target for Tyrosine Kinase Inhibitor Treatment
    Lopez-Mejia, Jose A.
    Tallabs-Utrilla, Luis F.
    Salazar-Sojo, Pablo
    Mantilla-Ollarves, Jessica C.
    Sanchez-Carballido, Manuel A.
    Rocha-Zavaleta, Leticia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
12345